Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
385.16
-2.48 (-0.64%)
At close: Jul 31, 2026, 4:00 PM EDT
386.80
+1.64 (0.43%)
After-hours: Jul 31, 2026, 7:50 PM EDT
Amgen Revenue
Amgen had revenue of $8.62B in the quarter ending March 31, 2026, with 5.76% growth. This brings the company's revenue in the last twelve months to $37.22B, up 9.07% year-over-year. In the year 2025, Amgen had annual revenue of $36.75B with 9.95% growth.
Revenue (ttm)
$37.22B
Revenue Growth
+9.07%
P/S Ratio
5.59
Revenue / Employee
$1,181,587
Employees
31,500
Market Cap
207.87B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 36.75B | 3.33B | 9.95% |
| Dec 31, 2024 | 33.42B | 5.23B | 18.57% |
| Dec 31, 2023 | 28.19B | 1.87B | 7.09% |
| Dec 31, 2022 | 26.32B | 344.00M | 1.32% |
| Dec 31, 2021 | 25.98B | 555.00M | 2.18% |
| Dec 31, 2020 | 25.42B | 2.06B | 8.83% |
| Dec 31, 2019 | 23.36B | -385.00M | -1.62% |
| Dec 31, 2018 | 23.75B | 898.00M | 3.93% |
| Dec 31, 2017 | 22.85B | -142.00M | -0.62% |
| Dec 31, 2016 | 22.99B | 1.33B | 6.14% |
| Dec 31, 2015 | 21.66B | 1.60B | 7.97% |
| Dec 31, 2014 | 20.06B | 1.39B | 7.43% |
| Dec 31, 2013 | 18.68B | 1.41B | 8.17% |
| Dec 31, 2012 | 17.27B | 1.68B | 10.80% |
| Dec 31, 2011 | 15.58B | 529.00M | 3.51% |
| Dec 31, 2010 | 15.05B | 411.00M | 2.81% |
| Dec 31, 2009 | 14.64B | -361.00M | -2.41% |
| Dec 31, 2008 | 15.00B | 232.00M | 1.57% |
| Dec 31, 2007 | 14.77B | 503.00M | 3.53% |
| Dec 31, 2006 | 14.27B | 1.84B | 14.79% |
| Dec 31, 2005 | 12.43B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Johnson & Johnson | 97.93B |
| Merck & Co. | 65.77B |
| AbbVie | 64.39B |
| Pfizer | 63.32B |
| AstraZeneca | 61.37B |
| Novartis AG | 56.69B |
| Sanofi | 54.60B |
| Novo Nordisk | 50.57B |
AMGN News
- 1 day ago - Amgen discloses data breach, says patient information was stolen - Reuters
- 1 day ago - Amgen says cybersecurity incident not likely to have material impact - TheFly
- 2 days ago - AMGEN ANNOUNCES 2026 THIRD QUARTER DIVIDEND - PRNewsWire
- 4 days ago - Amgen price target raised to $360 from $350 at Barclays - TheFly
- 4 days ago - AMGEN ANNOUNCES WEBCAST OF 2026 SECOND QUARTER FINANCIAL RESULTS - PRNewsWire
- 8 days ago - Amgen submits new data to challenge FDA's proposal to withdraw Tavneos - Reuters
- 10 days ago - Amgen reaches $74M lawsuit settlement over tax bill, Reuters reports - TheFly
- 11 days ago - Amgen settles shareholder lawsuit claiming it hid $10.7 billion tax bill - Reuters